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Abstract
Although hydroxyapatite (HAp) has been doped with dozens of different ions, the quest for an ion 
imparting a combination of properties conducive to bone healing is still ongoing. Because of its 
protean potency and the similarity in size and shape to the phosphate tetrahedron, selenite ion 
presents a natural ionic substitute in HAp. The incorporation of selenite into synthetic HAp using 
two different methods – co-precipitation and ion-exchange sorption - was studied for its effect on 
crystal properties and on a triad of biological responses: antibacterial, anticancer and 
osteoinductive. Co-precipitation yielded HAp with higher selenite contents than sorption and the 
stoichiometry of HAp richest in selenite was represented as Ca9.75(PO4)5.75(SeO3)0.25(OH)1.75. 
Crystallinity of HAp decreased in direct proportion with the amount of selenite incorporated. 
Because of their lower selenite content, HAp powders prepared by ion-exchange exhibited a 
consistently higher crystallinity compared to the co-precipitated ones. Annealing partially 
recovered the crystallinity, yet the difference in crystallinity between powders prepared by co-
precipitation and by ion-exchange remained, suggesting that the amorphization is mainly due to 
structural incorporation of selenite, not its effect on the crystal growth kinetics. The addition of 
selenite changed the morphology of HAp nanoparticles from acicular to rounded and affected the 
crystal lattice parameters in different ways depending on whether the powders were annealed or 
not. As for the annealed powders, the incorporation of selenite contracted the lattice in both a and 
c crystallographic directions. In the agar diffusion assay, the effectiveness of HAp was more 
dependent on the presence or absence of selenite in it than on its concentration and was highest 
against E. coli and S. aureus, moderately high against S. enteritidis and ineffective against P. 
aeruginosa. In liquid inoculation tests, on the other hand, the antibacterial activity of HAp was 
directly proportional to the amount of selenite contained in it. The viability of K7M2 
osteosarcoma cells decreased in direct proportion with the amount of selenite in HAp and was 
significantly different from the untreated control and from pure HAp at contents equal to or higher 
than 1.9 wt.%. In contrast, no reduction was observed in the viability of primary fibroblasts treated 
with HAp incorporating different amounts of selenite ions, suggesting their potentially selective 
anticancer activity: lethal for the cancer cells and harmless for the healthy cells. Finally, mRNA 
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expression of bone gamma-carboxyglutamate protein (BGLAP3) was higher in differentiated 
MC3T3-E1 osteoblastic cells treated with selenite-incorporated HAp particles than in cells treated 
with pure HAp. The osteoinductive effect was due to an overall higher metabolic activity of cells 
treated with the particles and not due to increased proliferation. In such a way, a triad of 
antibacterial, osteoinductive and anticancer activities was attributed to selenite-incorporated HAp.
1. Introduction
Being the mineral component of vertebrate hard tissues, hydroxyapatite (HAp) is naturally 
compatible with the biological systems, making it a material of choice for hard tissue 
engineering. Tissue engineering constructs have been generally designed as composites 
containing a polymeric phase and HAp1, but thanks to its viscous properties in the cement 
form2, HAp has been often used alone as a bone graft in maxillofacial and orthopedic 
surgeries3. It has also been used as a support structure in scaffolds owing to its large 
compressive strength4 as well as an osteoconductive component that promotes bone 
remodeling and regeneration5.
HAp is a versatile solid, capable of augmenting tissue engineering constructs with multiple 
other functionalities. A particularly popular application of HAp is as a drug carrier6 to 
deliver drugs such as bisphosphonates7, antibiotics8 and other antimicrobial agents9,10, 
anticancer chemotherapeutics11,12, et cetera. HAp also possesses a rare form of 
stoichiometric flexibility, given that its crystal structure can maintain the characteristic P63/m 
symmetry within a broad range of Ca/P molar ratios (1.3 – 2) and under a very high 
concentration of defects. This allows HAp to be doped with a wide range of chemical 
elements and groups. It was being reported that more than half of the elements of the 
Periodic Table could be incorporated inside HAp13. The use of HAp as a hard component of 
tissue engineering constructs has thus naturally progressed into a school of thought that 
advocates the incorporation of one or multiple types of ions into HAp and the adjustment of 
the stoichiometric composition so as to impart novel properties. Mg-HAp, for example, 
promoted mineralization as a coating on Ti implants more effectively than pure HAp14 and 
was also observed to possess a more osseointegrative nature than native HAp15, presumably 
owing to its increased resorption rate. Bone cell viability following incorporation of Co and 
Mn ions into HAp structure were also comparable to native HAp16. Mn was further reported 
to be beneficial for bone regeneration due to its induction of osteoblast proliferation and the 
propensity to positively influence the osteoblast metabolic activity17. Incorporation of Fe 
into HAp crystal structure to impart magnetic properties to the material18 and the resulting 
promotion of bone remodeling and tissue regeneration have also been reported19. Further, 
Fe-doped HAp has also been exploited for its superparamagnetic nature20 as well as to 
deliver drugs21 and boost the osteoblastic activity22, thus positively affecting bone 
regeneration. Cobalt-incorporated HAp has been shown to favor osteogenesis in vivo23, 
while also demonstrating an antibacterial activity24. A more extensive bone ingrowth and an 
improved bone tissue coverage of the implant have also been reported for Si-containing 
HAp25. HAp with the trace amounts of Ag ions was demonstrated as favorable as an 
antibacterial nanomaterial for dental and orthopedic implants26. Similar antibacterial 
activities were reported for Ce- and Eu-doped HAp27,28. The use of Sr as a dopant has been 
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justified by its well-known affinity toward bone and a potential therapeutic use in mitigating 
osteoporosis by enhancing the formation of new bone29. CO32− substitution of the PO43− 
group has been reported to enhance the bio-integration of HAp implants when studied in 
white rabbits30. Most recently, doping HAp with Hf endowed it with the ability to produce 
large concentrations of reactive oxygen species under ionizing radiation and made it a 
candidate for materials for photodynamic antitumor therapies31. However, although HAp has 
been doped with dozens of different ions in search of the perfect ionic substitute, the quest 
for an ion imparting a versatile combination of properties conducive to the bone healing 
process is still ongoing. In this study, we investigate an oxyanion of selenium for one such 
synergistic effect.
Once considered a toxic element, selenium (Se) is now known to be an essential 
micronutrient involved in various metabolic processes32. For example, it is a part of 
selenoenzymes, which prevent and reverse the oxidative damage, enabling Se to even act as 
an antidote against potent toxins, including mercury33. Not only does it possess pronounced 
antibacterial properties34 and is a potent antioxidant and chemopreventive agent in 
oncology35, but it also has a pronounced effect on bone development. For example, its 
deficiency inhibited bone growth36; its concomitant dosing with anastrazole prevented 
resorption and other symptoms of bone toxicity37; and its vitamin-supplemented 
administration to osteoporotic white rabbits restored the trabeculae density to a normal 
state38. Because of this protean potency, which makes it fundamentally similar to HAp in 
many respects39, as well as the almost identical size as the phosphate tetrahedron, selenite 
ion, SeO32−, presents a natural ionic substitute in HAp (Fig.1). Previous studies have shown 
that SeO32− incorporates well into HAp crystals and that it need not result in the formation 
of a separate phase40. The antibacterial activity of SeO32− ions also increased following their 
incorporation into HAp41. Even at the low weight content of 0.6 %, SeO32− ions in HAp 
inhibited P. aeruginosa and S. aureus from establishing biofilm42. Biocompatibility and the 
antibacterial activity of selenite-containing HAp (Se-HAp) could be utilized against biofilm 
formation on implants, which is a major source of infection following surgical 
implantation43,44. An immediate benefit of this approach would be reduced dependence of 
patients on strong antibiotics for prophylactic purposes. The incorporation of SeO32− into 
HAp has also been demonstrated to have a therapeutic effect against hepatocellular 
carcinoma in vivo45. Specifically, while the tumor volume and mass failed to be reduced 
four weeks after the intravenous injection of Se-HAp, the survival rate of treated vs. 
untreated mice differed significantly. The animals treated with Se-HAp had a 100% survival 
rate over a 36-day period compared to the untreated ones (55 %) and those treated with pure 
HAp (78 %). On top of being able to stop the progression of malignant tumors, Se clusters 
deposited on titania promoted the proliferation of healthy osteoblasts46,47, suggesting the 
potentially selective anticancer and osteogenic behavior of the oxyanions of this metal, 
which we have explored in this study. In total, we have followed the effects of SeO32− ions 
on the crystallinity and the crystal growth habit of HAp as well as on the antibacterial, 
osteoinductive and anticancer effects of selenite-doped HAp (Se-HAp) in vitro.
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2. Materials and methods
2.1. Preparation of HAp and selenite-containing HAp powders
To synthesize HAp, 88 ml of 0.1 M Ca(NO3)2 and 94 ml of 0.06 M (NH4)2HPO4 were 
mixed and 18 ml of 1 M NH4OH was added to the reaction mixture, which was then heated 
to 65 °C and maintained for an hour. To account for the later inclusion of selenite ions, Ca/P 
molar ratio in the solution from which HAp was precipitated was 1.56, lower than 1.67 
typifying stochiometric HAp. The formed suspension was allowed to cool at room 
temperature, before it was washed with deionized water. Prior to washing and after washing 
the precipitate was separated from the supernatant by centrifugation at 5000 rpm for 5 min. 
The precipitate was then dehydrated overnight in a vacuum oven at 80°C to obtain dry HAp 
powder.
Selenite-incorporated HAp (Se-HAp) was prepared using two different methods: (1) co-
precipitation and (2) post-precipitation, i.e., ion-exchange sorption. To make co-precipitated 
Se-HAp, varying amounts of sodium selenite were added to (NH4)2HPO4 solution so as to 
cover the 0 – 25 wt.% range with respect to the weight of HAp ionic components in the 
solution from which HAp was precipitated. The synthesis procedure was otherwise identical 
to that yielding pure HAp. Post-precipitation synthesis of Se-HAp incorporation was 
achieved by immersing the precipitated HAp powder in a sodium selenite solution (pH ~ 10) 
in concentrations in the range of 10 to 40 %w/w with respect to the weight of the solid phase 
for 48 h. The powders were washed with distilled water to eliminate the excess unbound 
selenite and dried as described above. The as-precipitated and dried powders were annealed 
at 800 °C for 3 h in a horizontal tube furnace (Acros International, STF1200) in air.
2.2. Physicochemical characterization
X-ray diffractometry was carried out on a Bruker D2 Phaser diffractometer and on powders 
pre- and post-annealing using 10 – 90 ° 2Θ range, the step size of 0.002°, and the scan time 
of 1.5 s/step. The average crystallite size was determined from the Scherrer equation using 
Diffrac.Eva XRD analysis software. Crystallinity of the powders (Xc) was calculated using 
the following relation, in which V112/300 is the intensity of the trough between the (112) and 
(300) reflections and I300 is the intensity of the (300) reflection48:
(Eq. 1)
Interplanar spacing (dhkl) was measured using the Bragg relation where λ is the wavelength 
of Cu Kα radiation, 1.5418 Å, and Θ is the diffraction angle for (hkl) reflection:
(Eq. 2)
The hexagonal lattice parameters of HAp, a and c, were calculated from dhkl using the 
following equation:
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(Eq. 3)
Transmission Electron Microscopy (TEM) studies were performed on a JEOL JEM 1220 
Life Science TEM operated at 80 kV. Inductively Coupled Plasma Mass Spectroscopy 
analysis was carried out at the Microanalysis Facility at the University of Illinois at Urbana-
Champaign.
2.3.Antibacterial assays
Annealed Se-HAp powders were tested for their antibacterial activity against Escherichia 
coli, Staphylococcus aureus, Staphylococcus epidermis, Salmonella enteritidis, and 
Pseudomonas aeruginosa using the agar diffusion and liquid inoculation assays. Ten mg of 
the powder were placed onto a bacterium-infused nutrient agar plate with the spot radius of 
1 cm. The powders were deposited as a paste by adding minute volumes (20 μl) of water to 
them and mixing well so that they did not spread while spotting. The plates were then 
allowed to incubate for 24 - 48 h at 37 °C. The zone of inhibition was used to gauge the 
antibacterial activity of the powders depending on their selenite content. Pure, Se-free HAp 
and vancomycin-loaded Se-HAp were used as negative and positive controls, respectively. 
All the samples for this assay were analyzed in triplicates. In the liquid inoculation test, a 
single colony of S. aureus cultured on a blood agar plate over a period of 24 h was stabbed 
with a pipette tip, placed in 5 ml of brain heart infusion broth (Sigma Life Sciences) 
containing 5 mg/ml Se-HAp, and incubated overnight at 37 °C and 170 rpm. The same 
procedure was repeated for E. coli. All the samples for this assay were analyzed in 
duplicates.
2.4. Anticancer studies
A viability assay was run using Vybrant MTT Cell Proliferation Assay Kit (Molecular 
Probes Inc.). K7M2 murine osteosarcoma cells (ATCC) were seeded at 5,000 cells/well in a 
Falcon 96-well plate and allowed to incubate for 48 h. Nanoparticles were then added at 2 
mg/ml and allowed to incubate for another 48 h. The MTT proliferation assay was run 
according to the Vybrant MTT Cell Proliferation Assay Kit protocol. Media were removed 
from each well and replaced with 100 ml of fresh media, along with 10 μl of 12 mM of MTT 
stock solution. The cells were incubated at 37 °C for 4 h. At the conclusion of the 
incubation, all but 25 μl of media were removed from each well, followed by the addition of 
50 μl of DMSO. Each well was stirred and the plate was allowed to incubate for 10 min. 
After the incubation, absorbance was read at 540 nm using a FLUOstar Omega microplate 
reader (BMG LabTech). To estimate cell viability, absorbance values were normalized to the 
difference between the absorbance of untreated negative controls and the absorbance of the 
pure medium. All the samples were analyzed in triplicates. The same test was performed on 
mouse primary lung fibroblasts isolated from 9 week old C57B6/J mouse lungs.
Immunofluorescent studies were performed on the same two types of murine cells: K7M2 
and primary lung fibroblasts. The cells were fixed and stained for nucleus, f-actin, and HAp. 
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They were fixed for 5 minutes in 4 % paraformaldehyde (PFA) and washed 3 × 10 min in 
phosphate buffered saline (PBS). Alexa Fluor 568 phalloidin (1:400) and OsteoImage 
reagent (1:100) were then added and incubated for 1 hour at room temperature. After the 
incubation, the cells were washed 3 × 5 min with OsteoImage wash buffer. Cells were then 
incubated in NucBlue® Fixed Cell ReadyProbes™ reagent (Molecular Probes, Life 
Technologies) for 5 - 10 min, rinsed in PBS and mounted on glass slides. Images were 
acquired on a Zeiss LSM 710 confocal microscope (UIC core imaging facility).
2.5. Osteoinductivity assay
Mouse calvarial preosteoblastic cell line, MC3T3-E1 subclone 4, was purchased from 
American Tissue Culture Collection (ATCC, Rockville, MD). The cells were seeded at 1.5 × 
105 cells/well in 24 well plates and cultured in 1 ml of Alpha Minimum Essential Medium 
(α-MEM; Gibco) supplemented with 100 ug/ml ascorbic acid and 10% fetal bovine serum 
(FBS, Invitrogen). After 17 days of incubation, the suspension containing 5 mg/ml of 
particles was added to the cells and incubated for 72 h. After the given time, cell lysis, 
reverse transcription (Bio-Rad) and qPCR (Applied Biosystems, StepONEPlus) were 
performed using the Taqman kit (Applied Biosystems) in accordance with the 
manufacturer's instructions. At the same time point, mineralized particles were stained with 
alizarin red by incubating the cells with it for 15 min. This was followed by fixation using a 
15-minute treatment with 10 % paraformaldehyde (PFA) and washing repeatedly with water 
in-between the steps. Each experiment was done in duplicates and each experimental replica 
was analyzed for mRNA expression in triplicates (n = 2 × 3). The real-time PCR data were 
analyzed using the ΔΔCt method49.
2.6. Statistical analysis
All biological experiments were conducted in triplicates unless noted otherwise and the 
results are expressed as means +− standard deviation (n ≥ 3). Student's t-test was used to 
estimate the statistical significance (p < 0.05) of difference between sample and control data 
points.
2.7. Ethics of animal experimentation
Complying with the federal regulations of animal research, animal experimentation 
protocols were approved by the Office of Animal Care and Institutional Biosafety (OACIB) 
at the University of Illinois at Chicago (UIC).
3. Results and Discussion
3.1. Physical characterization of Se-HAp
Selenite-incorporated HAp powders (Se-HAp) were synthesized in this study by two 
different methods: (1) co-precipitation and (2) ion exchange sorption, aka post-precipitation. 
On one hand HAp is used by the body as a mineral reservoir owing to its ability to easily 
undergo ionic substitutions and accommodate a variety of differently sized and charged ionic 
species, while on the other hand HAp has been used with success as an adsorbent in 
chromatographic columns50,51, gas sensors52 and environmental purification 
technologies53,54,55; hence the rationale for testing both of these methods for the capture of 
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selenite ions. Sorption of selenite proceeds by substituting phosphate groups on the surface 
of HAp56, yet in the case of co-precipitation the additional possibility for the bulk 
incorporation of selenite is likely to produce a higher ion incorporation efficiency. This 
expectedly lower level of incorporation of selenite ions into HAp via surface sorption than 
via co-precipitation was confirmed by the compositional analysis, the results of which are 
shown in Fig.2. In both cases, only a portion of dissolved SeO32− ions entered the HAp 
lattice. The highest achieved weight content of selenite was close to 3 wt.% for the co-
precipitated powders compared to ten times less (0.36 wt.%) for the post-precipitated ones, 
proving that SeO32− incorporation in co-precipitated powders is not limited to surface 
adsorption/complexation or ion exchange, but is majorly tied to substitution of phosphates in 
the interior of the particle. This range of selenite contents from 0.3 – 3 wt.% corresponds to 
the phosphate-to-selenite conversion ratios of 0.6 – 4.7 %. Technically, approximately one in 
20 phosphate groups gets substituted with selenite at the highest amount of incorporation. 
The stoichiometry of the resulting Se-HAp could be tentatively represented as 
Ca9.75(PO4)5.75(SeO3)0.25(OH)1.75 if we were not to take into account the inevitable 
presence of carbonate ions at phosphate sites too, typically yielding (CO3)x with 0.1 < x < 
0.4.
The change in size and morphology of HAp particles following incorporation of selenite is 
seen from TEM images (Fig.3). Annealed HAp is a mixture of ~ 5 nm sized spheres and 
particles acicular in shape, having the length of 50 – 100 nm and the width of 10 – 15 nm 
(Fig.3a). The coexistence of these two types of particles is indicative of the aggregational 
crystal growth that is characteristic for HAp57. Elongated morphologies are typical for HAp 
and result from its crystallographic tendency to grow faster along its hexagonal c-axis than 
in the directions parallel to the basal plane. However, with the incorporation of selenite, this 
tendency is lost and the particles gain a more isotropic shape, with sizes in the 20 – 50 nm 
range (Fig.3b). It is possible that SeO32− interferes with the aggregation of smaller, spherical 
and poorly crystalline primary HAp particles into more crystalline needles, as the result of 
which the crystallinity of Se-HAp is lower than that of HAp (EDS not shown). Although an 
increase in the heat content of the system usually favors the elongation of HAp 
particles58,59, such a tendency was hampered by the crystallographic effects of phosphate-to-
selenite substitution.
X-ray diffractograms of the synthesized HAp powders, both pure and selenite-doped, are 
shown in Figs.4-5. No samples comprised a separate selenite phase and they were all 
monophasic with the exception of the annealed Se-HAp with the highest amount of 
incorporated SeO32−, displaying the additional presence of calcium pyrophosphate (β-
Ca2P2O7). Per Eq.3, as SeO32− content in HAp increases, so does Ca/P molar ratio increase, 
favoring the precipitation of an additional phase. Diffraction peaks of pristine HAp broaden 
due to the incorporation of the SeO32− ion in place of the PO43− ion and the crystallinity of 
co-precipitated powders is inversely proportional to the SeO32− content. In an 
aforementioned study by Kolmas et al.41, the decrease in crystallinity paralleling the 
incorporation of SeO32− into HAp by co-precipitation using the same reactants as in our 
method was apparent, but less pronounced. In other studies60,61, on the other hand, the effect 
of diminished crystallinity was equally intense as that reported here. This amorphization 
effect might be closely tied to the incongruency of ion transfer at the HAp/solution interface. 
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First of all, HAp is typified by incongruent dissolution, releasing more Ca2+ than PO43− in 
the acidic milieu and more PO43− than Ca2+ under alkaline conditions62. Conversely, 
formation of phosphate network is the first step in nucleation of HAp, the reason for which 
high phosphate and low calcium concentrations favor HAp formation more than the other 
way around63 and are routinely used in biomimetic mineralization experiments64. As a 
result, the activation barriers for Ca2+ and HxPO4x-3 ions differ and the crystal growth rate 
can be twice higher at high [HxPO4x-3]/[Ca2+] ratios, even when the supersaturation ratio is 
the same65. The integration of selenite into this strained network of phosphate ions would 
distort the lattice growing around it and reduce its long-range order. Additionally, it may 
hinder the proneness of the lattice to dissolution/reprecipitation in a phosphate-rich solution, 
the mechanism through which the primary amorphous particles ripen into crystalline units. 
As a result, the HAp structure becomes effectively “frozen” in this transitory amorphous 
state. The third possible effect might come from SeO32− ion solutes in the double charge 
layer, which may be possible given only a small percentage of SeO32− ions that get 
incorporated into the lattice. In this case, SeO32− ions might suppress the Debye screening 
length and thus reduce the degrees of freedom in the stochastic process of coalescing 
nanoparticles’ seeking the most preferable orientation as they come into contact with each 
other, randomizing its outcomes and lowering the crystalline order in the system.
In the case of structurally analogous phosphate-to-carbonate substitution, occurring at room 
temperature and yielding so-called B-type carbonated HAp, the lattice parameter a decreases 
while the lattice parameter c increases66 due to the smaller radius of CO32− (178 pm) than 
that of PO43− (238 pm). In spite of the fact that the thermochemical radii of phosphate and 
selenite ions are almost identical, equaling 238 and 239 pm, respectively, both the lattice 
parameters a and c decreased in the annealed powders following phosphate-to-selenite 
substitution. Thus, as calculated from the 2θ shifts of (300) and (002) reflections shown in 
Fig.6, at the highest amount of incorporated SeO32− ions in annealed Se-HAp, d300 equaled 
2.717 Å and d002 equaled 3.431 Å compared to d300 = 2.719 Å and d002 = 3.437 Å for 
pristine HAp (Table 1). The corresponding unit cell dimensions decrease isotropically from 
a = 9.419 Å and c = 6.874 Å for pure HAp to a = 9.412 Å and c = 6.862 Å for HAp 
containing 3 wt.% SeO32−. This contraction of HAp lattice following SeO32− incorporation, 
observed earlier too67, can be explained by two effects: a) the flatter shape of trigonal 
SeO32− pyramids than that of PO43− tetrahedra; b) the paired Ca2+ and OH− vacancies 
forming as the result of every phosphate–to-selenite substitution to rebalance the charge, as 
in accordance with the following equation:
(Eq. 3)
In contrast, as the result of increased interatomic distances consequential to amorphization, 
the incorporation of selenite in as-precipitated HAp expanded the lattice parameter c, as seen 
from the shift in 2θ value for the (002) diffraction maximum in Fig.6. As also seen from Fig.
6, (300) peak exhibited significant broadening following incorporation of selenite, whereas 
the effect was noticeable, but significantly less pronounced for the (002) peak. This was 
corroborated in the TEM analysis of the evolution of the particle morphology as a function 
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of the selenite content. In other words, the evolution of the crystallite morphology from 
acicular to round must be due to the impeded growth along the basal plane and not the screw 
axis of hexagonal crystals. The recovery of crystalline order along the basal plane, i.e. in the 
[300] axis direction, was only partial following annealing, whereas that along the c-axis of 
the hexagonal lattice, i.e. in the [002] axis direction, was complete. The diminishment of the 
crystalline order consecutive to the incorporation of selenite ions was, thus, significantly 
more pronounced along the basal plane than along the c-axis and paralleled the reduction in 
elongation of particle shapes as a function of the selenite content.
The crystallite size estimated from the broadening of the most intense, (211) reflection 
decreased in inverse proportion with the selenite content (Fig.7). All Se-HAp powders, 
regardless of the formation route, demonstrate this trend. As far as the as-precipitated 
powders are concerned, this decrease is most intense at the onset of the selenite 
incorporation, at its lowest weight content, with any further increases in this content leading 
to little or no change in the crystallite size. This is in contrast to the trend observed for 
annealed co-precipitated powders, where a successive increase in the selenite content leads 
to a corresponding drop in the crystallite size. Annealing the co-precipitated powders 
mitigated this amorphization effect caused by selenite ions only at low SeO32− contents (0 – 
1.2 wt.%). At higher SeO32− contents, however, the decrease in the crystallite size as the 
function of SeO32− content becomes ever more drastic following annealing. Thus, as could 
be seen from Fig.7a, whereas the average crystallite size estimated from the Scherrer 
equation drops from 33 to 12 nm as SeO32− is added to HAp in 1.2 wt.% for non-annealed 
co-precipitated powders, it increases from 43 to 52 nm at the same amount of SeO32− for the 
annealed co-precipitated powders. However, while the crystallite size drops by more than 5 
times, i.e. from 33 to 6 nm, as SeO32− content increases from 0 to 3 wt.% for non-annealed 
co-precipitated powders, it decreases by more than 4 times, i.e. from 43 to 10 nm for the 
annealed co-precipitated powders in the same SeO32− content range. As far as the annealed 
powders prepared via ion-exchange sorption are concerned, no significant change in the 
crystallite size was observed depending on the selenite content. Annealing the post-
precipitated powders, in contrast to the co-precipitated ones, also completely mitigated the 
trend of amorphization caused by selenite ions. As could be seen from Fig.7b, whereas the 
crystallite size of HAp dropped from 34 to 22 nm as SeO32− was added to it in its highest 
amount for non-annealed post-precipitated powders, it increased from 43 to 48 nm for the 
annealed post-precipitated powders in the same SeO32− content range. Fig.7c-d 
demonstrates that the crystallite size at identical selenite contents was larger for post-
precipitated powders than for co-precipitated ones, be they annealed or not. This is a direct 
consequence of the ability of selenite to incorporate itself in the bulk of the nanoparticles 
only when it is co-precipitated together with Ca2+, PO43− and OH− ions. Selenite 
incorporates into the co-precipitated powders during the formation of the crystal and 
becomes isotropically distributed throughout the crystal lattice, as opposed to its surface 
substitution of phosphates in post-precipitated powders. For this reason, the effect of selenite 
on HAp properties is more pronounced for co-precipitated powders.
With the difference in the anionic size being negligible between phosphate and selenite, the 
lattice strain and its effects on crystallinity must be due to the coupled Ca2+ and OH− 
vacancies in the lattice forming as the result of the need to compensate the substitution of 
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trivalent phosphate with divalent selenite. Another reason why the crystallinity of HAp 
diminishes in direct proportion with selenite content may come from the effect of SeO32− 
ion on nucleation and crystal growth of HAp. It was observed that the admixtures containing 
17.0 and 22.7 wt.% of selenite tend to precipitate even without the addition of the base, 
suggesting the ability of SeO32− ion to act as a nucleation promoter, thus increasing the 
nuclei density and decreasing the size of the final crystallites. In contrast, at lower selenite 
contents (5.6 and 11.3 wt.%), the solutions containing Ca2+ and HxPO4x-3 required the 
addition of a base to increase the pH and drive the precipitation reaction to completion.
The amorphization of HAp as the result of incorporation of selenite ions is further seen from 
the consistently lower crystallinity of the co-precipitated powders than the post-precipitated 
ones, as estimated from Eq.1 (Fig.8). Annealing partially recovers the crystallinity, but 
retains the same level of difference in crystallinity between the co-precipitated and the post-
precipitated powders (Fig.8). This indicates that the amorphization is mainly due to 
structural effects, not the crystal growth effects. The way selenite gets incorporated in the 
lattice is more critical in explaining this effect than its possible modification of the crystal 
growth kinetics.
3.2. Biological characterization of Se-HAp
3.2.1. Antibacterial activity of Se-HAp—Results of the blood agar assay are presented 
in Fig.9 as inhibition zone diameters vs. selenite content in Se-HAp for four types of 
bacteria - E. coli, S. aureus, S. enteritidis and P. aeruginosa - and four types of samples: co-
precipitated Se-HAp, post-precipitated Se-HAp, co-precipitated Se-HAp loaded with 
vancomycin as the positive control, and pure, SeO32−-free HAp as the negative control. Se-
HAp powders demonstrated a higher antibacterial activity than HAp against all four 
bacterial strains tested in the blood agar assay. This shows that the antibacterial effectiveness 
of Se-HAp is due to the presence of SeO32− rather than HAp itself. HAp alone demonstrated 
a finite antibacterial activity only against E. coli, which was surpassed only by the post-
precipitated Se-HAp containing the highest concentration of selenite (0.36 wt.%) and the co-
precipitated Se-HAp containing the two highest concentrations of selenite (1.92 and 3 wt.
%).
Se-HAp powders also demonstrated a significantly lower antibacterial activity than the 
vancomycin-loaded Se-HAp against all four types of bacteria. Although there was some 
increase in the zones of inhibition and in the corresponding antibacterial activity with an 
increase in the selenite content, e.g., against E. coli, this activity was often dependent on the 
sole presence of selenite in HAp rather than on its concentration. This suggests that the 
antibacterial effect on agars is mostly due to a direct surface contact between selenite on the 
particle surface and the bacterium rather than the release of ions or the internal structure of 
the particle. Se-HAp powders were most effective against E. coli and S. aureus, with the 
greatest effect seen in E. coli. For S. enteritidis, the inhibition was seen at higher weight 
contents of selenite, most pronouncedly at 1.92 wt.%. At this concentration of selenite, the 
inhibition of S. enteritidis was similar to that seen around the vancomycin-loaded Se-HAp 
control.
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The antibacterial activity was higher for the co-precipitated powders than for the post-
precipitated ones. Even though the concentration of selenite on the particle surface may be 
the same for co-precipitated and post-precipitated powders, the turnover of the highly mobile 
surface of HAp ensures that the co-precipitated powders provide for a steadier selenite 
surface content over time. The post-precipitated powders showed little to no antibacterial 
activity, with only the 0.36 wt.% Se-HAp powder being active against E. coli and 
comparable in effect to the 0.1 wt.% co-precipitated Se-HAp. Neither the vancomycin-
loaded Se-HAp nor any other powders were considerably effective against the gram-
negative, biofilm-forming P. aeruginosa. In contrast, the addition of vancomycin to the 
powders increased their effect against both the gram-positive, biofilm-forming S. aureus and 
the non-biofilm-forming, gram-negative E. coli and S. enteritidis.
Liquid inoculation assays corroborated the higher antibacterial activity of Se-HAp against E. 
coli than against S. aureus. Previously, we have shown that HAp in general has a greater 
antibacterial activity against the gram-negative bacteria, e.g. E. coli, than against the gram-
positive ones, e.g. S. aureus68. Here, in liquid inoculations containing Se-HAp powders with 
the two highest SeO32− weight contents, 1.92 and 3 wt.%, the number of E. coli colony 
forming units (CFU) was significantly lower than in broths containing either HAp powders 
with no selenite (5 – 7 times at days 2 – 3) or untreated control (4.5 - 5.5 times at days 2 – 3) 
throughout the duration of the assay, i.e. up to 72 h (Fig.10a). In contrast, the activity of Se-
HAp powders against S. aureus was less consistently extended in time than that against E. 
coli, albeit present for certain Se-HAp compositions even after 72 h of the treatment when 
compared against selenite-free HAp (Fig.10b). The antibacterial activity of Se-HAp against 
S. aureus was most pronounced 24 hours after the inoculation of the Se-HAp-treated culture 
and by 48 hours the bacterial population had largely recovered to the untreated control 
levels, suggesting that the S. aureus that survived the initial Se-HAp treatment was no longer 
susceptible to selenite, regardless of its concentration in Se-HAp (Fig.10b). In contrast, E. 
coli remained susceptible to selenite at the highest concentrations, even by 72 hours post-
treatment (Fig.10a).
3.2.2. Anticancer activity of Se-HAp—Viability of K7M2 mouse osteosarcoma cells 
decreased in direct proportion with the amount of selenite in HAp and was significantly 
different from the untreated control and from pure HAp at selenite contents equal to or 
higher than 1.9 wt.% (Fig.11). Pure HAp, interestingly, increased the cell viability to 130 % 
of the negative control, while Se-HAp richest in the selenite content, the 3 wt.% Se-HAp, 
reduced the viability of osteosarcoma cells by 50 % compared to pure HAp and by 60 % 
compared to the untreated control. In contrast, the viability of primary fibroblasts treated 
with either pure HAp or HAp incorporating different amounts of SeO32− ions was not 
reduced (Fig.11). The viability curve as a function of the SeO32− content in Se-HAp dipped 
at lower SeO32− contents, but then recovered as the latter increased to 3 wt.%. This result 
shows that Se-Hap has selective toxicity for transformed cancer cells, while not affecting the 
viability of noncancerous primary cells. A similar selective anticancer activity in vitro was 
previously ascribed to HAp alone. For example, HAp nanoparticles added at 200 μg/ml 
exhibited size-dependent apoptotic effects on HepG2 hepatoma cells, but caused no toxicity 
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in normal, L-02 human hepatocytes69. They also had toxic effects on MG63 osteosarcoma 
cells, but left regular osteoblasts intact70.
To assess the cell/particle interaction, the interface between Se-HAp and both K7M2 
osteosarcoma cells and primary lung fibroblasts was analyzed through the use of 
immunofluorescent staining (Fig.12). Co-precipitated and annealed HAp powder containing 
1.24 wt.% selenite was chosen for the analysis since the treatment with 1.24 wt.% Se-HAp 
did not cause significant cell death in either osteosarcoma cells or primary fibroblasts (Fig.
11). Examination of the cell/particle interface showed that the uptake of Se-HAp particles by 
either cell type does not appear to affect the morphology of the cell, disrupt the actin 
cytoskeleton or cause any noticeable nuclear damage. Both cell types responded in a similar 
manner when treated with either Se-HAp or HAp. Since the morphological effects of 
selenite-to-phosphate substitution are notable at this selenite content (1.24 wt.%, Fig.3), this 
indirectly demonstrates that the detrimental effects of Se-HAp on cancer cells are, dose-
dependently, due to the presence of SeO32− ions in HAp. Selenite was previously shown to 
induce apoptotic hepatocyte death via oxidative damage and the corresponding induction of 
the imbalance of intracellular glutathione redox cycle in a dose-dependent manner71. The 
mechanism by which selenite destroyed human bladder cancer cells is complex and 
consisted of a combination of mitochondrial and DNA damage, leading to death via 
apoptosis, necrosis and autophagy runaway typified by vacuolar shrinkage and loss of 
adherence72. Cell death mechanisms caused by selenite ions are, therefore, variable and 
highly dose- and cell-dependent.
3.2.3. Osteoinductive activity of Se-HAp—To determine if Se-HAp has an 
osteoinductive effect on osteoblast-like cells, quantification of the expression of bone 
gamma-carboxylglutamate (BGLAP3), an osteocalcin-related protein, was carried out on 
semi-differentiated MC3T3-E1 cells treated with Se-HAp powders containing different 
amounts of selenite ion. To that end, MC3T3-E1 cells pretreated with DMEM supplemented 
with ascorbic acid for 17 days were treated with Se-HAp in which the selenite weight 
content ranged from 0.1 - 3 wt.%. The absolute BGLAP3 expression increased in direct 
proportion with the amount of SeO32− in Se-HAp and was higher than in the control, 
untreated cells or cells treated with selenite-free HAp particles (Fig.13a). Relative to the 
expression of β-actin as a housekeeping gene, BGLAP3 expression demonstrated the same 
trend: as selenite concentration in Se-HAp increased, from 0.1 to 1.92 wt.%, a 
corresponding increase in BGLAP3 expression was seen, with the highest expression 
detected in cells treated with 1.23 wt.% Se-HAp (Fig.13c). Cells treated with 3 wt.% Se-
HAp displayed a significantly reduced expression of BGLAP3 compared to the untreated 
control and to the osteoblastic cells treated with Se-free HAp (Fig.13c). However, the cells 
treated with 3 wt.% Se-HAp were also morphologically abnormal and showed signs of cell 
death by 24 hours. Interestingly, the administration of Se-HAp to semi-differentiated 
MC3T3-E1 cells promoted the expression of GAPDH in direct proportion with the selenite 
concentration in Se-HAp, exhibiting a trend similar to that observed for BGLAP3 (Fig.13b). 
While normally thought of as a housekeeping gene that plays a role in energy metabolism, in 
recent years GAPDH has been found to be involved in regulating other cell functions, 
including cell proliferation, tumorigenesis and apoptosis73. The highest expression of 
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GAPDH was seen in cells treated with HAp containing 1.92 wt.% of selenite, which is the 
same concentration of selenite at which the viability of K7M2 cells was reduced by 50% 
(Fig.11), suggesting that the addition of Se-HAp activates signaling pathways involved in 
cell death, which in turn affect the expression of GAPDH in the cell. Finally, following the 
treatment with Se-HAp containing the largest amount of selenite, i.e. 3 wt.%, the cell death 
becomes pervasive and a sudden drop in the GAPDH expression is registered (Fig.13b). It is 
worth noting that the gene expression assays were carried out on MC3T3-E1 cells semi-
differentiated for 17 days because Se-HAp, regardless of the weight content of SeO32−, had 
an invariably lethal effect on undifferentiated, pre-osteoblastic MC3T3-E1 cells at the tested 
dose of 2 mg ml-1.
GAPDH expression is known to be elevated in stressed cells, the reason for which this gene 
has been proposed as an intracellular sensor of oxidative stress during early apoptosis74. 
This upregulation of GAPDH (Fig.13b) indicates that the osteoinductive effect of Se-HAp is 
due to an overall higher metabolic activity of cells treated with these particles. It was 
previously observed that the imposition of mechanochemical stress on osteoblastic MC3T3-
E1 cells can have an augmentative effect on the expression of osteogenic markers75. 
Although it can have a protective, antioxidative effect on cells under attack of different 
species76, selenite is an oxygen specie that itself can exert an oxidative stress on the 
cells77,78 and such form of stress has been shown to be capable of leading to increased bone 
production in osteoblastic cells79. Mitochondria are tightly related to oxidative stress, which 
is essential to their function in spite of leading to permanent cell damage and/or cell death if 
excessive80. Also, a number of pro-inflammatory molecular mediators act as components of 
regeneration pathways within the cell81, suggesting that the activation of pro-inflammatory 
cytokines can be a stimulus for new bone growth. It is possible that SeO32− ions impose a 
concordant effect on the cells: they may induce stress to levels that boost the cell metabolism 
and activate the osteogenic pathways within the cell. At higher concentrations of selenite, 
however, e.g. 3 wt.%, the oxidative stress overwhelms the cell and causes it to activate the 
apoptotic pathways, with the cell death becoming the predominant outcome. This effect was 
observed in mineral formation too: although selenite promoted mineral formation at low 
contents in Se-HAp, it simultaneously exerted detrimental effects on cell morphology and 
viability, which resulted in no mineral formation at higher weight contents of selenite (Fig.
13d). In a bigger picture, such a promotion of beneficial effects through stress imposition 
agrees with the recently observed decrease in the health span, but increase in longevity as 
the result of selenium deficiency in diet82. Finally, in view of the different effects Se-HAp 
had on three different cell lines and four different bacterial species utilized in this study, we 
could conclude that the effect of Se-HAp is intensely cell- and bacterium-dependent. Such 
varying effects of SeO32− ions depending on the cell line and bacterial species were 
documented before83,84.
4. Conclusion
The exceptional lattice strain tolerance and charge compensation capacity of HAp crystal 
lattice endows it with the potential to accommodate a plethora of foreign ions, ranging from 
as light as lithium85 to as heavy as uranium86 and including both cations and anions. This 
ability of HAp, along with its sparsely soluble nature, makes it possible to act as a mineral 
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reservoir of the body and can be harnessed for various therapeutic effects through 
incorporation of specific and functional ions. In this study, we have shown that selenite, an 
anion almost identical in size to the phosphate ion, can improve the properties of pure HAp 
in a threefold manner: anticancer, antibacterial and osteoinductive. The incorporation of 
selenite into HAp increased its antibacterial activity against E. coli and endowed it with 
activity against S. enteritidis and S. aureus. Unlike the zones of inhibition, the bacterial 
concentrations in broths decreased in direct proportion with the content of selenite in HAp. 
As a corollary of its antibacterial activity, selenite was verified as a stress-imposing anion in 
bone cells. However, this imposition of stress, particularly noticeable at the weight content 
of selenite > 2 wt.%, led to an increased expression of an osteocalcin precursor, BGLAP3, in 
the cells, thus indicating the ability of HAp to promote a higher rate of new bone formation 
following the partial phosphate-to-selenite substitution. HAp powders containing the two 
highest concentrations of selenite ions also had pronounced inhibitory effects on the 
osteosarcoma cell line, while leaving the regular fibroblasts intact. Changes in the particle 
morphology and crystallinity following the incorporation of selenite were also documented. 
More sophisticated synthesis methods coupled to more detailed structural refinement studies 
should be the next step in the harnessing of the therapeutic effects of selenite delivered using 
HAp as the carrier. These and similar findings are expected to better our understanding of 
the effects of the natural compositional variability of bone on its properties87 and increase 
our capacity to utilize this understanding for various therapeutic ends.
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Fig.1. 
Hexagonal crystal structure of HAp (space group P63/m) in which a trigonal selenite 
pyramid (yellow) has substituted one of six phosphate tetrahedra (green) accommodated 
inside a single unit cell of HAp. Columnar, Ca1 ions are shown in magenta and the 
hexagonal, Ca2 ions are shown in blue, while channel hydroxyl groups are depicted in 
turquoise.
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Fig.2. 
Selenite content of the co-precipitated and post-precipitated Se-HAp powders and the 
phosphate-to-selenite conversion ratio as a function of the weight proportion of selenite ions 
in the synthesis solution.
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Fig.3. 
Transmission electron micrographs of annealed co-precipitated HAp (a) and Se-HAp 
containing 1.2 wt.% of selenite (b).
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Fig.4. 
X-ray diffractograms of (a) as-precipitated and (b) annealed HAp powders containing 
different weight percentages of selenite and synthesized by the co-precipitation method. 
Reflections originating from HAp are labeled with their corresponding Miller indices, 
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whereas reflections originating from calcium pyrophosphate (β-Ca2P2O7) are labeled with 
●.
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Fig.5. 
X-ray diffractograms of (a) as-precipitated and (b) annealed HAp powders containing 
different weight percentages of selenite and synthesized by the post-precipitation method. 
Reflections originating from HAp are labeled with their corresponding Miller indices.
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Fig.6. 
A change in the (002) and (300) diffraction peaks of HAp following the incorporation of 3 
wt.% of selenite by co-precipitation before (a, c) and after (b, d) annealing.
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Fig.7. 
Crystallite size as a function of selenite content for the following HAp powders: (a) co-
precipitated powders before ( ) and after ( ) annealing; (b) post-precipitated powders 
before ( ) and after ( ) annealing; (c) as-precipitated powders prepared by co-
precipitation ( ) and post-precipitation ( ); (d) annealed powders prepared by co-
precipitation ( ) and post-precipitation ( ).
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Fig.8. 
Crystallinity as a function of selenite content for the following HAp powders: co-
precipitated powders before ( ) and after ( ) annealing; post-precipitated powders 
before ( ) and after ( ) annealing.
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Fig.9. 
Diameters of inhibition zones around annealed co-precipitated and post-precipitated Se-HAp 
with different contents of selenite in the agar diffusion test against E. coli, S. aureus, S. 
enteritidis, and P. aeruginosa. Co-precipitated Se-HAp powders loaded with vancomycin (V 
+ co-prec. Se-HAp) and HAp particles with no selenite and no added antibiotic (HAp) were 
used as positive and negative controls, respectively. Blue and red triangles are invisible 
because of the overlap with purple triangles at 0 cm zone diameters. Blue squares are 
invisible at 0.48 cm for 1.92 wt.% co-precipitated Se-HAp and at 0.1 cm for 3 wt.% co-
precipitated Se-HAp because of the overlap with a blue circle and a pink square, 
respectively.
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Fig.10. 
Concentrations of E. coli (a) and S. aureus (b) in a liquid broth inoculation assay of co-
precipitated and annealed Se-HAp powders containing different amounts of selenite and no 
added antibiotics. Assays were run after different incubation times, ranging from 1 to 4 days. 
Data are shown as averages with error bars representing standard deviation. Data points 
significantly lower than the untreated control (C-, p < 0.05) are topped with a black asterisk. 
Data points significantly lower than Se-free HAp (0 wt.%, p < 0.05) are topped with a blue 
asterisk.
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Fig.11. 
Cell viability of K7M2 mouse osteosarcoma cells ( ) and primary fibroblasts ( ) 
exposed to annealed Se-HAp with various weight contents of selenite synthesized by co-
precipitation. The dashed line at 100 % viability denotes the viability of untreated cells, to 
which the viabilities of cells treated with HAp and Se-HAp were normalized.
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Fig.12. 
Immunofluorescent optical images of primary lung fibroblasts (a-c) and K7M2 
osteosarcoma cells (d-f) following a 24 h interaction with either no particles (a, d) or HAp 
(b, e) and Se-HAp (c, f) particles containing 1.24 wt.% selenite. Cell nucleus is stained in 
green, f-actin in blue, and HAp/Se-HAp particles in red.
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Fig.13. 
Absolute mRNA expression of BGLAP3 (a) and GAPDH (b) normalized to the expression 
of GAPDH in control cell population for differentiated MC3T3-E1 cells treated with 
different Se-HAp particles. (c) mRNA expression of BGLAP3 relative to the expression of 
β-actin in differentiated MC3T3-E1 cells treated with different Se-HAp particles. (d) 
Mineral coverage per mm2 of surface seeded with MC3T3-E1 pre-osteoblastic cells as a 
function of the weight percentage of selenite in annealed Se-HAp synthesized by co-
precipitation. Bars and error bars represent averages and standard deviations, respectively. 
Standard deviation is invisible to the eye in (b). Data points statistically significantly higher 
or lower (p < 0.05) compared to the control are marked with an asterisk.
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Table 1
Crystallographic parameters of annealed HAp and Se-HAp containing the maximal concentration of selenite 
ions for different synthesis conditions.
HAp system d300 (Å) d002 (Å) Lattice parameter a (Å) Lattice parameter c (Å)
HAp 2.719 3.437 9.419 6.874
Se-HAp 2.717 3.431 9.412 6.862
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